米他扎品(Mirtazapine)—新抗抑郁药

被引:8
作者
顾牛范
笪志民
机构
[1] 上海市精神卫生中心
关键词
抗抑郁药; 环类; 阿米替林; Mirtazapine; 不良反应; 安慰剂; 空白剂; 受体亲和力; 抗精神病药; 三哇酮; 本品;
D O I
暂无
中图分类号
R971 [神经系统药物];
学科分类号
1007 ;
摘要
<正> 抑郁症是一种常见病多发病,在不同国家不同文化背景及不同的社会经济层次均可发生。据国外统计,在成年中平均每年有11.3%的人患各种精神抑郁障碍。与常见的躯体疾病(如高血压、糖尿病、肺部慢性感染)相比,抑郁症对人类健康带来较大的危害,致残性更严重。
引用
收藏
页码:258 / 261
页数:4
相关论文
共 7 条
[1]  
Mirtazapine, a novel antidepressant in the treatment of anxiety symptoms.Results from a placebo-controlled trial. Sitsen JMA and Moors J. Drug Investigation . 1994
[2]  
Lifetime and 12-month prevalence of DSM-Ⅲ-R psychiatric disorders in the United States. Kessler RC et al. Archives of General Psychiatry . 1994
[3]  
Affective disorders in the United States Communities. Weissman MM et al. Psychological Medicine . 1988
[4]  
The rational for long-term antidepressant therapy. Kasper S. Inter Clin Psychopharmacology . 1993
[5]  
The effect of noradrenergic drugs on Serotonin metabolism in the nucleus raphe dorsalis of the rat study by in vitro voltametry. Clement HH et al. European Journal of Pharmacology . 1992
[6]  
The α2 antagonist Remeron enhance Serotonin trasmission in vivo. De Boer T et al. European Journal of Pharmacology . 1994
[7]  
Efficacy of Mirtazapine and Amitriptyline in patients with major depressive disorder: a meta-analysis. Zivkov M et al. Human Psychopharmacology . 1995